MannKind Repays Certain Debt Obligations

MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns

Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?

MannKind Announces CFO Transition

Jim Cramer Says You Should Avoid These 11 Stocks

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8

MannKind Corporation Announces Participation at Upcoming Conferences

Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts

MannKind Full Year 2023 Earnings: Beats Expectations

MannKind Corporation (NASDAQ:MNKD) Q4 2023 Earnings Call Transcript

Q4 2023 MannKind Corp Earnings Call